Skip to main content

Senseonics Holdings, Inc.

corporate_fare Company Profile

Senseonics Holdings, Inc.

SENS·NASDAQ·Industrial Applications And Services·CIK 0001616543

We are a medical technology company focused on developing and selling long-term, implantable continuous glucose monitoring (CGM) systems. Our Eversense implantable CGM system, which includes Eversense E3 and Eversense 365, is designed to continuously and accurately measure glucose levels in people with diabetes. The system uses an under-the-skin sensor, a removable and rechargeable smart transmitter, and a mobile app for real-time monitoring. Eversense 365 can monitor glucose for up to twelve months, and Eversense E3 for six months, significantly longer than the seven to 15 days of non-implantable CGM systems. In September 2024, the 365-day extended life Eversense E3 CGM system received FDA approval, and we began commercializing Eversense 365 in the fourth quarter of 2024 through Ascensia Diabetes Care Holdings AG. In January 2026, we assumed full commercial responsibility for Eversense 365 in the United States, marketing and distributing the product with our own sales force. In June 2022, we affixed the CE Mark to the Eversense E3 CGM system, and Ascensia began commercialization in select European markets during the third quarter of 2022. In January 2026, the Company obtained CE Mark approval for Eversense 365. Before the current Eversense systems, we sold Eversense systems that measured glucose for up to 180 days in the United States, and prior to that, 90 days in both the United States and select European markets. In September 2017, we affixed the CE Mark to the Eversense XL CGM system for sale in select markets in Europe and the Middle East. In June 2018, we obtained FDA approval for the 90-day Eversense CGM system for distribution throughout the United States. In June 2019, we received FDA approval for the non-adjunctive indication (dosing claim) for the 90-day Eversense system.

Senseonics Holdings, Inc. (NASDAQ:SENS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for SENS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-09, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 17 rated 8 or above. Recent SEC coverage for SENS spans 10-Q, 8-K, 424B5, DEF 14A.

Recent high-impact activity:

  • Senseonics 10-Q: Q3 Revenue $19.6M, $32.7M Loss, $126.3M Cash Into 2028
  • Senseonics Posts $32.7M Third-Quarter Loss
  • Senseonics Partners with Beta Bionics to Integrate Eversense 365 with iLet Bionic Pancreas
  • Senseonics Finalizes Acquisition of European Eversense CGM Commercial Assets
  • Eversense 365 Shows Strong Real-World Performance at ADA, Validating One-Year CGM System

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$35.26M
Net Income
-$69.11M
Diluted EPS
-$1.66
Op. Cash Flow
-$59.13M
Free Cash Flow
-$60.24M
Gross Profit
$15.76M
Operating Income
-$68.34M
Cash & Equivalents
$40.23M
Total Debt
$35.59M
Debt / Equity
0.58×
Net Margin
-196.0%
Shares Outstanding
41.27M sh
Source: 10-K · filed 2026-03-02 · accession 0001104659-26-022298

Short Interest & Short Volume

7.80 days to cover

FINRA reported short interest of 4,738,794 shares in SENS as of the October 30, 2026 settlement, a 2.7% decrease from the prior period — about 7.8 days to cover at its recent average daily volume. On November 20, 2026, 19.4% of SENS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,738,794 shares as of October 30, 2026
Change vs prior period▼ 2.7%
Days to cover7.80 at avg daily volume of 607,554
Daily short volume (FINRA facilities)19.4% of 602,718 shares on November 20, 2026
5-day average short volume20.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with S →
$8 -0.20% today
52-week range · as of 2026-11-09 $4.79 – $10.64
Market cap
$439.34M
Volume
1.4M (1.4× avg)
3-mo avg 989.3K
Live data · 2026-11-22 09:32 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SENS - Latest Insights

SENS
Nov 09, 2026, 4:23 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $10.36
Real-time Price: $8.00 info
Change: -$2.36 (-23%) info
Market Cap: $439.34M info
SENS
Nov 09, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $10.20
Real-time Price: $8.00 info
Change: -$2.20 (-22%) info
Market Cap: $439.34M info
SENS
Sep 14, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.78
Real-time Price: $8.00 info
Change: -$0.7764 (-9%) info
Market Cap: $439.34M info
SENS
Jun 08, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.13
Real-time Price: $8.00 info
Change: +$0.8736 (+12%) info
Market Cap: $439.34M info
SENS
Jun 06, 2026, 5:00 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $6.57
Real-time Price: $8.00 info
Change: +$1.43 (+22%) info
Market Cap: $439.34M info
SENS
May 20, 2026, 4:29 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $5.63
Real-time Price: $8.00 info
Change: +$2.37 (+42%) info
Market Cap: $439.34M info
SENS
May 07, 2026, 4:45 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $5.41
Real-time Price: $8.00 info
Change: +$2.59 (+48%) info
Market Cap: $439.34M info
SENS
May 07, 2026, 4:37 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $5.46
Real-time Price: $8.00 info
Change: +$2.54 (+47%) info
Market Cap: $439.34M info
SENS
May 07, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.40
Real-time Price: $8.00 info
Change: +$2.60 (+48%) info
Market Cap: $439.34M info
SENS
May 04, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.01
Real-time Price: $8.00 info
Change: +$2.99 (+60%) info
Market Cap: $439.34M info
SENS
May 01, 2026, 4:07 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $5.15
Real-time Price: $8.00 info
Change: +$2.86 (+55%) info
Market Cap: $439.34M info
SENS
Apr 30, 2026, 9:52 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $5.61
Real-time Price: $8.00 info
Change: +$2.39 (+43%) info
Market Cap: $439.34M info
SENS
Apr 30, 2026, 5:03 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $5.68
Real-time Price: $8.00 info
Change: +$2.32 (+41%) info
Market Cap: $439.34M info
SENS
Apr 30, 2026, 4:28 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $5.70
Real-time Price: $8.00 info
Change: +$2.30 (+40%) info
Market Cap: $439.34M info
SENS
Apr 06, 2026, 5:18 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $6.68
Real-time Price: $8.00 info
Change: +$1.33 (+20%) info
Market Cap: $439.34M info
SENS
Mar 27, 2026, 5:04 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $6.44
Real-time Price: $8.00 info
Change: +$1.57 (+24%) info
Market Cap: $439.34M info
SENS
Mar 12, 2026, 4:13 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $5.60
Real-time Price: $8.00 info
Change: +$2.40 (+43%) info
Market Cap: $439.34M info
SENS
Mar 12, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.55
Real-time Price: $8.00 info
Change: +$2.45 (+44%) info
Market Cap: $439.34M info
SENS
Mar 02, 2026, 4:37 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $8.06
Real-time Price: $8.00 info
Change: -$0.0564 (-0.70%) info
Market Cap: $439.34M info
SENS
Mar 02, 2026, 4:33 PM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $8.02
Real-time Price: $8.00 info
Change: -$0.0169 (-0.21%) info
Market Cap: $439.34M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets